Leading the way in the research and production of 3D cell culture solutions

Who are we?

We are a young, innovative, research-led company that designs, develops and creates novel solutions to tissue culture limitations to meet your research needs.

What is our Company Mission?

The Company’s mission is to provide bespoke products that allow our customers to fully exploit the in-vitro culture of cells in applications related to regenerative medicine, diseases such as cancer and diabetes, in-vitro drug screening and for incorporation into bioinks.

What is different about our products?

  • Our PhenoDrive products promote the formation of 3D cell spheroids from 2D culture systems without need for gels.
  • PhenoDrives are animal component free and are provided as lyophilised powders that are easily reconstituted and incorporated into your existing protocols.
  • PhenoDrives are a range of fully synthetic, biomimetic materials to provide simple, single step solutions to promote your cell culture models and preserve phenotype through mimicry of the extra cellular matrix.
  • Nanosperse allows the simple dispersal of nanoparticles for individual testing and study

Where are we based?

We are based in the city of Brighton and Hove, East Sussex, England



Company registered


Grant awarded from Innovate UK


Beta Testing begins on PhenoDrive-R and PhenoDrive-U


Cell-Based Models for Neurodegeneration Study and Use in Screening (CENSUS) awarded under the H2020-Fast Track to Innovation call.


H2020-FTIPilot 730678 CENSUS project begins


PhenoDrive-R and PhenoDrive-U product launch


Beta Testing begins on PhenoDrive-Y


PhenoDrive-Y product launch


Beta Testing begins on PhenoDrive-I


New large grant awarded - announcement coming soon!

Jan 2019

EU signing of the RESTORE Health by Advanced Therapies

May 2019

H2020 MEFISTO project launch - https://www.mefisto-project.eu

June 2019

New development and manufacturing facilities open for business

August 2020

Innovate UK grant awarded for the development of a rapid point of care test kit for the detection of COVID-19

Funded By

Horizon 2020 research and innovation programme.

The EU project MEFISTO is taking on the challenge of developing innovative ways of using bioactive functionalised materials to prevent the onset of osteoarthritis following meniscus loss. Tissue Click Ltd is providing the bioactive mimics to manipulate the cells surrounding the implants to modify their behaviour. https://www.mefisto-project.eu

Funded By

Innovate UK, the UK’s innovation agency.

Along with its European partner the University of Salerno, we are developing a kit for the sensitive, rapid and inexpensive diagnosis of Covid-19 infection. The project has been co-funded by Innovate UK,  under the competitive funding scheme UKRI Open call for research and innovation ideas to address COVID-19.

Funded By

Horizon 2020 Large-scale research initiative programme

The RESTORE project is a comprehensive 10 year programme to increase the awareness of advanced therapies to the European Commission, European Parliament, scientific community, patient advocates and the public.

Funded By

Horizon 2020 European Funding for Research & Innovation

Along with three other partners we are working on the CENSUS project which is working towards providing a technical solution for neurodegenerative disorders. The project will produce CNS cell models from a consistent, renewable source, in the form of induced pluripotent stem cells (iPSC); will manufacture 3D scaffolds in multiwell culture plates by micro-extrusion technology.

Our Key Team

Discover the TissueClick staff credentials

Dr Anna Guildford

Technology Exploitation Manager

Dr. Guildford is the Technology Exploitation Manager at Tissue Click Ltd. Anna has over 20 years of experience in the field of cell biology, tissue engineering and regeneration. She joined Tissue Click Ltd in October 2017 where she has since lead the development, manufacture and more recently the exploitation of the PhenoDrive product portfolio.

Flavia Bonalumi

Company Scientist

Flavia Bonalumi is a Laboratory Scientist at Tissue Click Ltd, where she is focused on the delivery of an aptamer-based diagnostic kit for the early and rapid detection of COVID. Flavia is also currently finishing her Ph.D. at the Pharmacy and Biomolecular Science department at the University of Brighton. The project focuses on the development of innovative macroporous materials to be used in BAL systems. She holds a degree in Biomedical Engineering at the Politecnico di Milano and a Master's degree in Tissue Engineering and Biotechnology.

Sophia Khan

Company Scientist

Sophia Khan is a full-time laboratory scientist at Tissue Click Ltd. She is currently completing an MRes in Regenerative Medicine and Devices at the University of Brighton with an integrated placement at Tissue Click Ltd. Her project's main focus is observing MSCs phenotype and cell migration cultured on plates coated with PhenoDrive.

Want to discuss your project further with the TissueClick team?  Contact us


Contact us to order